Patents by Inventor Keith A. Moore

Keith A. Moore has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD OF TREATING POST-SURGICAL ACUTE PAIN
    Publication number: 20170128400
    Abstract: A method is provided for treating pain in patients recovering from post-surgical trauma by administering between about 13 to about 30 mg of diclofenac potassium in a liquid dispersible formulation over a period of at least 24 hours, wherein the daily total amount of diclofenac potassium administered is less than or equal to about 100 mg. The method is particularly useful in treating acute pain in bunionectomy patients.
    Type: Application
    Filed: January 12, 2017
    Publication date: May 11, 2017
    Inventors: Mark M. Kowalski, James L. Young, Keith A. Moore
  • Method of treating post-surgical acute pain
    Patent number: 9561200
    Abstract: A method is provided for treating pain in patients recovering from post-surgical trauma by administering between about 13 to about 30 mg of diclofenac potassium in a liquid dispersible formulation over a period of at least 24 hours, wherein the daily total amount of diclofenac potassium administered is less than or equal to about 100 mg. The method is particularly useful in treating acute pain in bunionectomy patients.
    Type: Grant
    Filed: December 20, 2013
    Date of Patent: February 7, 2017
    Assignee: Depomed, Inc.
    Inventors: Mark M. Kowalski, James L. Young, Keith A. Moore
  • TRANEXAMIC ACID FORMULATIONS
    Publication number: 20150290127
    Abstract: Disclosed are modified release oral tranexamic acid formulations and methods of treatment therewith.
    Type: Application
    Filed: June 19, 2015
    Publication date: October 15, 2015
    Inventors: Keith A. Moore, Ralph A. Heasley, Jeffrey S. Greiwe, John W. Facemire, Jason D. Modest
  • TRANEXAMIC ACID FORMULATIONS
    Publication number: 20150290157
    Abstract: Disclosed are immediate release oral tranexamic acid formulations and methods of treatment therewith.
    Type: Application
    Filed: February 12, 2015
    Publication date: October 15, 2015
    Inventors: Keith A. Moore, Ralph A. Heasley, Jeffrey S. Greiwe, John W. Facemire, Jason D. Modest
  • Tranexamic acid formulations
    Patent number: 9060939
    Abstract: Disclosed are modified release oral tranexamic acid formulations and methods of treatment therewith.
    Type: Grant
    Filed: September 13, 2011
    Date of Patent: June 23, 2015
    Assignee: Ferring B.V.
    Inventors: Keith A. Moore, Ralph A. Heasley, Jeffrey S. Greiwe, John W. Facemire, Jason D. Modest
  • Tranexamic acid formulations with reduced adverse effects
    Patent number: 8968777
    Abstract: Tranexamic acid formulated in an oral dosage form with at least one agent that decreases tranexamic acid release in the stomach. Such formulations minimize nausea, vomiting, and other adverse gastric effects that may accompany tranexamic acid therapy, for example, to treat heavy menstrual bleeding. One embodiment is an extended release formulation with waxes, polymers, etc. that prevent a bolus release of tranexamic acid in the stomach. An alternative embodiment is a delayed release formulation with polymers that prevent release of tranexamic acid in the acid environment of the stomach and delay its release until the formulation reaches the less acid environment of the intestines. Such formulations enhance patient compliance with therapy because adverse effects of tranexamic acid therapy are reduced.
    Type: Grant
    Filed: February 3, 2006
    Date of Patent: March 3, 2015
    Assignee: Ferring B.V.
    Inventors: Ralph A. Heasley, Keith A. Moore, Jeffrey S. Greiwe, John W. Facemire, Jason D. Modest
  • Tranexamic acid formulations
    Patent number: 8957113
    Abstract: Disclosed are immediate release oral tranexamic acid formulations and methods of treatment therewith.
    Type: Grant
    Filed: January 28, 2011
    Date of Patent: February 17, 2015
    Assignee: Ferring B.V.
    Inventors: Keith A. Moore, Ralph A. Heasley, Jeffrey S. Greiwe, John W. Facemire, Jason D. Modest
  • TRANEXAMIC ACID FORMULATIONS
    Publication number: 20150018419
    Abstract: Disclosed are modified release oral tranexamic acid formulations and methods of treatment therewith.
    Type: Application
    Filed: July 25, 2014
    Publication date: January 15, 2015
    Applicant: Ferring B.V.
    Inventors: Keith A. Moore, Ralph A. Heasley, Jeffrey S. Greiwe, John W. Facemire, Jason D. Modest
  • Tranexamic acid formulations
    Patent number: 8809394
    Abstract: Disclosed are modified release oral tranexamic acid formulations and methods of treatment therewith.
    Type: Grant
    Filed: July 9, 2012
    Date of Patent: August 19, 2014
    Assignee: Ferring B.V.
    Inventors: Keith A. Moore, Ralph A. Heasley, Jeffrey S. Greiwe, John W. Facemire, Jason D. Modest
  • Tranexamic acid formulations
    Patent number: 8791160
    Abstract: Disclosed are modified release oral tranexamic acid formulations and methods of treatment therewith.
    Type: Grant
    Filed: September 14, 2012
    Date of Patent: July 29, 2014
    Assignee: Ferring B.V.
    Inventors: Keith A. Moore, Ralph A. Heasley, Jeffrey S. Greiwe, John W. Facemire, Jason D. Modest
  • METHOD OF TREATING POST-SURGICAL ACUTE PAIN
    Publication number: 20140107210
    Abstract: A method is provided for treating pain in patients recovering from post-surgical trauma by administering between about 13 to about 30 mg of diclofenac potassium in a liquid dispersible formulation over a period of at least 24 hours, wherein the daily total amount of diclofenac potassium administered is less than or equal to about 100 mg. The method is particularly useful in treating acute pain in bunionectomy patients.
    Type: Application
    Filed: December 20, 2013
    Publication date: April 17, 2014
    Applicant: Depomed, Inc.
    Inventors: Mark M. Kowalski, James L. Young, Keith A. Moore
  • Method of treating post-surgical acute pain
    Patent number: 8623920
    Abstract: A method is provided for treating pain in patients recovering from post-surgical trauma by administering between about 13 to about 30 mg of diclofenac potassium in a liquid dispersible formulation over a period of at least 24 hours, wherein the daily total amount of diclofenac potassium administered is less than or equal to about 100 mg. The method is particularly useful in treating acute pain in bunionectomy patients.
    Type: Grant
    Filed: August 8, 2011
    Date of Patent: January 7, 2014
    Assignee: Depomed, Inc.
    Inventors: Mark M. Kowalski, James L. Young, Keith A. Moore
  • Tranexamic acid formulations
    Patent number: 8487005
    Abstract: Disclosed are modified release oral tranexamic acid formulations and methods of treatment therewith.
    Type: Grant
    Filed: September 14, 2012
    Date of Patent: July 16, 2013
    Assignee: Ferring B.V.
    Inventors: Keith A. Moore, Ralph A. Heasley, Jeffrey S. Greiwe, John W. Facemire, Jason D. Modest
  • Tranexamic Acid Formulations
    Publication number: 20130096198
    Abstract: Disclosed are modified release oral tranexamic acid formulations and methods of treatment therewith.
    Type: Application
    Filed: July 9, 2012
    Publication date: April 18, 2013
    Applicant: FERRING B.V.
    Inventors: Keith A. Moore, Ralph A. Heasley, Jeffrey S. Greiwe, John W. Facemire, Jason D. Modest
  • Tranexamic Acid Formulations
    Publication number: 20130018100
    Abstract: Disclosed are modified release oral tranexamic acid formulations and methods of treatment therewith.
    Type: Application
    Filed: September 14, 2012
    Publication date: January 17, 2013
    Applicant: FERRING B.V.
    Inventors: Keith A. Moore, Ralph A. Heasley, Jeffrey S. Greiwe, John W. Facemire, Jason D. Modest
  • Tranexamic Acid Formulations
    Publication number: 20130012584
    Abstract: Disclosed are modified release oral tranexamic acid formulations and methods of treatment therewith.
    Type: Application
    Filed: September 14, 2012
    Publication date: January 10, 2013
    Applicant: FERRING B.V.
    Inventors: Keith A. Moore, Ralph A. Heasley, Jeffrey S. Greiwe, John W. Facemire, Jason D. Modest
  • Coal treatment process for a coal-fired power plant
    Patent number: 8298304
    Abstract: A coal treatment process containing a coal-beneficiation process module. The module is implemented into the conventional coal treatment process of a coal-fired power plant after a first step of grinding the coal in a coal mill. The process module sequentially extracts chemical substances of non-combustible ash, water, mercury and oil that are found in coal before the coal is fired, so that present invention can produce valuable products and achieve a high quality cleaned powdered coal-char to burn in a furnace to thereby reduce pollution and increase the efficiency of energy production from the coal.
    Type: Grant
    Filed: February 20, 2009
    Date of Patent: October 30, 2012
    Assignee: Castle Light Corporation
    Inventor: Keith A. Moore
  • Tranexamic acid formulations
    Patent number: 8273795
    Abstract: Disclosed are modified release oral tranexamic acid formulations and methods of treatment therewith.
    Type: Grant
    Filed: August 13, 2008
    Date of Patent: September 25, 2012
    Assignee: Ferring B.V.
    Inventors: Keith A. Moore, Ralph A. Heasley, Jeffrey S. Greiwe, John W. Facemire, Jason D. Modest
  • Tranexamic Acid Formulations
    Publication number: 20120122985
    Abstract: Disclosed are modified release oral tranexamic acid formulations and methods of treatment therewith.
    Type: Application
    Filed: September 13, 2011
    Publication date: May 17, 2012
    Inventors: Keith A. Moore, Ralph A. Heasley, Jeffrey S. Greiwe, John W. Facemire, Jason D. Modest
  • Method of treating post-surgical acute pain
    Patent number: 8110606
    Abstract: A method is provided for treating pain in patients recovering from post-surgical trauma by administering between about 13 to about 30 mg of diclofenac potassium in a liquid dispersible formulation over a period of at least 24 hours, wherein the daily total amount of diclofenac potassium administered is less than or equal to about 100 mg. The method is particularly useful in treating acute pain in bunionectomy patients.
    Type: Grant
    Filed: February 16, 2010
    Date of Patent: February 7, 2012
    Assignee: Aaipharma Services Corp.
    Inventors: Mark M. Kowalski, James L. Young, Keith A. Moore